Epoch is the Total BioDesign company developing natural solutions to unnatural problems. We are designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $11M
Investors 6
Date | Name | Website |
- | The Ventur... | theventure... |
25.10.2023 | Plug and P... | plugandpla... |
27.08.2022 | TechX | netzerotc.... |
25.06.2022 | Amadeus Ca... | amadeuscap... |
18.07.2022 | Cambridge ... | cambridgea... |
- | BoxGroup | boxgroup.c... |
Funding Rounds 1
Date | Series | Amount | Investors |
22.06.2022 | Seed | $11M | - |
Mentions in press and media 1
Date | Title | Description |
22.06.2022 | Epoch Biodesign Raises $11M in Seed Funding | Epoch Biodesign, a London, UK-based Total BioDesignTM Company, raised $11M in seed funding. The round was led by Lowercarbon Capital, with participation from BoxGroup, Amadeus Capital Partners, MCJ Collective, Zero Carbon capital, VOYAGERS ... |